Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_assertion type Assertion NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_head.
- NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_assertion wasGeneratedBy ECO_0000203 NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_provenance.
- NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_assertion wasDerivedFrom befree-2016 NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_provenance.
- NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_assertion SIO_000772 18952979 NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_provenance.
- NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_assertion evidence source_evidence_literature NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_provenance.
- NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_assertion description "[Temozolomide (TMZ)-based therapy is the standard of care for patients with glioblastoma multiforme (GBM), and resistance to this drug in GBM is modulated by the DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699976.RAC9c0JFWmqZaHnNVSSTcJ4CyIM67vlMvcajC6Xf7hObU130_provenance.